Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $24.8 million.

  • Icu Medical's Shares Outstanding (Diluted Average) rose 141.17% to $24.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 141.17%. This contributed to the annual value of $24.4 million for FY2024, which is 123.28% up from last year.
  • Latest data reveals that Icu Medical reported Shares Outstanding (Diluted Average) of $24.8 million as of Q3 2025, which was up 141.17% from $24.7 million recorded in Q2 2025.
  • Icu Medical's 5-year Shares Outstanding (Diluted Average) high stood at $24.8 million for Q3 2025, and its period low was $21.7 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $24.1 million (2023), whereas its average is $23.7 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 1003.32% in 2022, then increased by 28.73% in 2024.
  • Icu Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $21.8 million in 2021, then rose by 9.58% to $23.9 million in 2022, then increased by 0.93% to $24.1 million in 2023, then increased by 1.23% to $24.4 million in 2024, then grew by 1.62% to $24.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $24.8 million for Q3 2025, versus $24.7 million for Q2 2025 and $24.5 million for Q1 2025.